The first European GMP & GDP Forum will be held from 22-24 June 2021, both as an on-site meeting in Heidelberg, Germany, or Live Online. Please read more here
In the life science industry, surfaces pose different risks for the process depending on whether and how long they are in contact with the medicinal product. Please read more here
The work environment and focus of regulatory agencies have changed, in some cases significantly, in 2020, particularly as a result of Covid-19. Please read more here
Many European pharmaceutical companies seek to enter the Russian market, but have little to no experience with the Russian authorities and their inspectors. Please read more here
